Medical Research

Download the Clinical Trial

The MacuMira clinical trial, published in the International Journal of Retina and Vitreous, found the following:

of patients in the treatment group showed improved vision

of patients improved by at least 10 letters on the ETDRS acuity chart

Average improvement, along with a 25% average increase in ETDRS acuity

adverse effects of treatment

of treated patients maintained their vision improvements for the duration of the trial

During the trial period, placebo group participants’ visual acuity decreased by 2 ETDRS letters read on average.

Corporate:
#302, 815 – 1st Street SW
Calgary, AB
T2P 1N3
info@macumira.com
1-844-619-6263

Mailing Address:
MacuMira Medical Devices Inc
#136 1811 4th Street SW
Calgary, AB
T2S 1W2

Hours:
Mon-Fri: 8am – 5pm
Sat – Sun: Closed